Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.

Molecular & cellular proteomics : MCP - 1 Jun 2008

Duncan James S, Gyenis Laszlo, Lenehan John, Bretner Maria, Graves Lee M, Haystead Timothy A, Litchfield David W

Abstract excerpt

Recently protein kinases have emerged as some of the most promising drug targets; and therefore, pharmaceutical strategies have been developed to inhibit kinases in the treatment of a variety of diseases. CK2 is a serine/threonine-protein kinase that has been implicated in a number of cellular pr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzimidazoles
Share to Casein Kinase II
Share to Chemistry, Pharmaceutical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Drug Evaluation, Preclinical

Share to Inhibitory Concentration 50

Share to Models, Chemical

Share to Triazoles

Source

Identifiers

PMID: 18258654
DOI: 10.1074/mcp.M700559-MCP200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18258654-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.PMID 18258654Read ↗

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.Semantic proximity Read ↗

Development and exploitation of CK2 inhibitors.Semantic proximity Read ↗

Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.Semantic proximity Read ↗

Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2Semantic proximity Read ↗

Features and potentials of ATP-site directed CK2 inhibitors.Semantic proximity Read ↗

2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.Semantic proximity Read ↗

Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cellsSemantic proximity Read ↗

Identification of CK2α’ selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound librarySemantic proximity Read ↗

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.Semantic proximity Read ↗

Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma ManagementSemantic proximity Read ↗

Targeting CK2 in cancer: a valuable strategy or a waste of time?Semantic proximity Read ↗

Therapeutic targeting of CK2 in acute and chronic leukemiasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.